Skip to main content
. Author manuscript; available in PMC: 2012 Mar 15.
Published in final edited form as: Cancer. 2010 Nov 8;117(6):1227–1235. doi: 10.1002/cncr.25605

Table 1.

Distribution of selected characteristics of the patient cohort (n =1,287)

Total SPM-Free SPM


Variable No. % No. % No. % P-valuesc
Total patients 1,287 100 1,167 90.7 120 9.3
Age
 ≤ median (57 years) 664 51.6 625 53.6 39 32.5 < .001
 > median (57 years) 623 48.4 542 46.4 81 67.5
Sex
 Male 977 75.9 883 75.7 94 78.3 0.515
 Female 310 24.1 284 24.3 26 21.7
Ethnicity
 Non-Hispanic White 1,089 84.6 995 85.3 94 78.3 0.050
 Other 198 15.4 172 14.7 26 21.7
Smoking
 Never 345 26.8 320 27.4 25 20.8 0.121
 Ever 942 73.2 847 72.6 95 79.2
Alcohol
 Never 336 26.1 309 26.5 27 22.5 0.345
 Ever 951 73.9 858 73.5 93 77.5
Index Cancer Site
 Oral cavity 416 32.3 378 32.3 38 31.7 0.316
 Oropharynx 575 44.7 527 45.2 48 40.0
 Larynx/Hypopharynx 296 23.0 262 22.5 34 28.3
Index Cancer Stage
 I or II 324 25.2 292 25.0 32 26.7 0.693
 III or IV 963 74.8 875 75.0 88 73.3
Treatment
 Surgery only 229 17.8 208 17.8 21 17.5 0.889
 Surgery + Adjuvant Txa 320 24.9 287 24.6 33 27.5
 XRTb 329 25.5 301 25.8 28 23.3
 XRT + Chemotherapy 409 31.8 371 31.8 38 31.7
a

Adjuvant Treatment: adjuvant radiotherapy and/or chemotherapy

b

XRT: radiotherapy

c

P values were calculated from chi-square test